CE Certification Diagnostic Reagent Filling Machine Factories – COVID-19 Detection reagent equipment – CILIANG
CE Certification Diagnostic Reagent Filling Machine Factories – COVID-19 Detection reagent equipment – CILIANG Detail:
Neutralizing antibody against SARS-CoV-2 can resist human immune SARS-CoV-2 infection.
Therefore, the detection of neutralizing antibodies against SARS-CoV-2 has important clinical significance for patients with convalescent infection or for vaccination of SARS-CoV-2 vaccine.
The SARS-CoV-2 Neutralizing Antibody Test Kit is for the qualitative detection of neutralizing antibodies to SARS-CoV-2 in human serum, plasma or whole blood sample. The test kit is intended for use outside the body only (in vitro diagnostic use) for professional use and should not be used to diagnose acute SARS-CoV-2 infection.
Analyzer
Test Kit
Product
Method
Specimen type
Specimen volume
Test time
Package size
Storage
SARS-CoV-2 Neutralizing Antibody Test Kit
Fluorescence Immunochromatography
Serum, plasma or whole blood sample
25µl
10 minutes
25 pcs/box; 50 pcs/box
4℃~30℃
Product detail pictures:


Related Product Guide:
We always think and practice corresponding to the change of circumstance, and grow up. We purpose at the achievement of a richer mind and body as well as the living for CE Certification Diagnostic Reagent Filling Machine Factories – COVID-19 Detection reagent equipment – CILIANG, The product will supply to all over the world, such as: Libya, Croatia, Uruguay, So far our merchandise have been exported to east Europe, the Middle East, Southeast, Africa and South America etc. We have now 13years experienced sales and purchase in Isuzu parts at home and abroad and the ownership of the modernized electronic Isuzu parts checking systems. We honor our core principal of Honesty in business, priority in service and will do our best to provide our customers with high quality items and excellent service.

This supplier stick to the principle of "Quality first, Honesty as base", it is absolutely to be trust.
